Live on Bloomberg TV

00:00What is the rationale for listing in Hong Kong. Did you consider listing in the US. Did you consider listing here on the mainland limiting sang on that. And that's a the tongue in Hong Kong's capital markets is mostly similar to the after mainland. Its understanding of healthcare is also similar as China's system is very different from foreign ones. So antigen arguments and that's all good. Dow Jones. ISE. Cheshire. And that of time. You mean you go you Dow Jones handles. Each country's healthcare industry is relevant today. Government policies. That's why we think listing in Hong Kong is a good choice. This shows us a dance. Emma Chandra. Emma Chandra. How are you going to prioritize putting the capital that you've raised through the IPO to use for the business. Are you going to just wait until day a woman. The question no need is asking you. First we will focus on strengthening our core business. For example our supply chain which still has room to improve even though we are the largest retailer in China's healthcare sector. Secondly we want to connect our online offline medical services as soon as possible. Third we want to have some cash reserves. It's good to have cash at any time in case of any difficulty. NIKKEI another woman Cornell West a woman. In addition we want to improve the ecosystem of our core business including investments or acquisition it yet letting know heinous and have with you. How has the pandemic impacted the online healthcare business here in China. Entirely on their soil. That's a shame. You know it's from a long term perspective. The pandemic has pushed the health care industry forward. They see a lot more Chinese people are now participating in online medical services to enjoy it in general. Each farm corner Tung Power. China has entered a normalisation of epidemic control but online medical consultation won't decline. This is the epidemic peak come to an end which means consumer behavior has already been profoundly changed. You know she won't Jihye Lee. She won't be sent in again. What is a realistic number. What is a realistic target in terms of user numbers by the end of 2021 for example. These are suggested tong. From my perspective we're very likely to have more than 100 million users. Well let's talk about competition and it is a very competitive space with the likes of Alibaba Health and Ping and good doctor. How do you differentiate yourselves from your competitors here. Sandy Yeah. I mean this idea to fit on with ISE compared to the entire Chinese healthcare industry or the three main players are very small. And we are all trying to change consumer behavior in light of this. We are business friends on the same mission of encouraging users to use medical services online. We are not necessarily competitors. Woman feeding into gender. So how do you think the new anti-trust laws that China is working on will impact the country's tech sector longer to make a high independent of billions of dollars. Each industry has different criteria and few companies leading the industry can be innovation leaders. What can also be the monopolist who curbs innovation is possible to launch A by election and to it at a higher level. Of course is necessary to establish standards are government level to define innovation and monopolies. And we welcome any reasonable government regulations. Jan CAC. Tom Glor yours. Hogwash. I that China's healthcare market is over one and a half trillion dollars or GDP health even as the number one player is only one and a half billion. So it's very hard to monopolize the healthcare market. That's at the high end. You know ISE internal affairs after Dow Jones.

No schedule data available.

BTV Channel FinderWatch BTV in your area

JD Health Projects Over 100 Million Users By End of 2021

JD Health International Inc. surged in the largest stock market debut by a health-care firm in Asia as investors look past increasing regulatory scrutiny to bet that demand for online medical services will continue to grow in post-Covid China. JD Health CEO Xin Lijun discusses the listing in an exclusive interview with Bloomberg's Tom Mackenzie. (Source: Bloomberg)

More From Daybreak Asia
All episodes and clips

Bloomberg Markets
"Bloomberg Markets" is focused on bringing you the most important global business and breaking markets news and information as it happens.
More episodes and clips